OpenAlex
Works that cite this article, indexed by OpenAlex.
Willingness to pay for one quality-adjusted life year in Iran
Cost Effectiveness and Resource Allocation 17(1) (2019)
Najmeh Moradi; Arash Rashidian; Shirin Nosratnejad; Alireza Olyaeemanesh; Marzieh Zanganeh; Leila Zarei
Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran
DARU Journal of Pharmaceutical Sciences 25(1) (2017)
Fatemeh Teimouri; Abbas Kebriaeezadeh; Seyed Mohsen Zahraei; Mohammadmahdi Gheiratian; Shekoufeh Nikfar
An exploratory study to estimate cost-effectiveness threshold value for life saving treatments in western Iran
Cost Effectiveness and Resource Allocation 18(1) (2020)
Najmeh Moradi; Abraha Woldemichael; Parisa Malekian; Delnia Moradi Rotvandi; Satar Rezaei
Cost-utility analysis of Macitentan Vs. Bosentan in pulmonary atrial hypertension
Journal of Family Medicine and Primary Care 9(7) (2020)
Marzieh Nosrati; Nikinaz Ashrafi Shahmirzadi; Monireh Afzali; Pardis Zaboli; Hasti Rouhani; Haleh Hamedifar; Mirhamed Hajimiri
The Use of EQ-5D in the Middle East and North Africa Region: A Systematic Literature Review
PharmacoEconomics 43(8) (2025)
Abeer Al Rabayah; Sibylle Puntscher; Fatima Al Sayah; Razan Derar Sawalha; Elly A. Stolk; Judit Simon; Michael Drummond; Uwe Siebert
Cost-Effectiveness of Ibrutinib as First-line Treatment for Older Patients With Chronic Lymphocytic Leukemia in Iran
Value in Health Regional Issues 38 (2023)
Soroush Fariman; Fatemeh Samadi Nasab; Hoda Faraji; Monireh Afzali
A scoping review on patient heterogeneity in economic evaluations of precision medicine based on basket trials
Expert Review of Pharmacoeconomics & Outcomes Research 22(7) (2022)
Marzieh Nosrati; Shekoufeh Nikfar; Mandana Hasanzad
Az egészségügyi forrás allokáció aktuális kérdései Iránban; egészségügyi technológiaelemzés (Current issues of healthcare resource allocation in Iran; Health Technology Assessment)
Köz-gazdaság 14(1) (2019)
Mahsid Moradi; Agnes Zs. Kovacs
Intravenous and subcutaneous vedolizumab for moderately to severely active ulcerative colitis in Iran: a model-based cost-effectiveness evaluation
Expert Review of Pharmacoeconomics & Outcomes Research 25(6) (2025)
Kimia Niksalehi; Anita Oyarhossein; Soroush Fariman; Adel Ahmadi; Behniya Azadmehr; Naeim Karimpour-Fard; Laleh Vaziri; Monireh Afzali